Last reviewed · How we verify

NCT06964152: AI-VT

Computational Cardiac Imaging Analysis to Guide Ventricular Tachycardia Ablation Procedures (AI-VT)

ENROLLING BY INVITATION NA Last updated 9 May 2025
What this trial tests

NA trial testing Computational electrocardiography and cardiac computed tomography mapping in Ventricular Tachycardia (VT) in 250 participants. Enrolling by invitation.

Timeline
1 May 2024
Primary endpoint
31 December 2029
31 December 2034

Quick facts

Lead sponsorUniversity of California, San Diego
PhaseNA
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment250
Start date1 May 2024
Primary completion31 December 2029
Estimated completion31 December 2034
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of California, San Diego

Who can join

Adults 21 to 90, any sex, with Ventricular Tachycardia (VT) or Premature Ventricular Contraction (PVC). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate the clinical outcomes (clinical efficacy and safety) of using supplemental non-invasive computational ECG and cardiac imaging analysis tools to help guide ablation of ventricular tachycardia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Ventricular Tachycardia (VT)

Currently open trials in the same condition.

Other University of California, San Diego trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06964152.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing